We are live on ! Find out more
ZOM

Zomedica Corp.
ZOM

Delisted

ZOM was delisted on the 4th of March, 2025.

Back to rankings

Fund managers haven’t disclosed any holdings of ZOM yet.

ZOM Hedge Fund Activity: Q1 2026 in Review

8 of the 8,130 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q1 2026, worth a combined $123K — down 2.7% from $126K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new ZOM positions and 1 closed out — a net gain of 1 holder — while 2 added to existing stakes and 1 trimmed.

The largest buyer was Gill Capital Partners, opening a new position worth an estimated $325. The largest seller was Ancora Advisors, cutting an estimated $25.8K.

  • 8 institutional investors held Zomedica Corp. (ZOM) as of Q1 2026, up from 7 in Q4 2025.
  • Funds reported $123K of Zomedica Corp. stock for Q1 2026, down 2.7% quarter-over-quarter.
  • 2 funds opened new Zomedica Corp. positions in Q1 2026 and 1 closed out, a net change of +1 holder.
  • The largest Zomedica Corp. buyer in Q1 2026 was Gill Capital Partners, an estimated $325 added.
  • The largest Zomedica Corp. seller in Q1 2026 was Ancora Advisors, an estimated $25.8K sold.

Based on aggregated 13F filings for Q1 2026.